These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3204001)
1. Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Ogan MD Invest Radiol; 1988 Dec; 23(12):961. PubMed ID: 3204001 [No Abstract] [Full Text] [Related]
2. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174 [TBL] [Abstract][Full Text] [Related]
3. MR contrast enhancement of intracranial lesions with Gd-DTPA. Hesselink JR; Press GA Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078 [TBL] [Abstract][Full Text] [Related]
4. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA]. Pronin IN; Kornienko VN Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134 [TBL] [Abstract][Full Text] [Related]
5. Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging. Johnston DL; Liu P; Lauffer RB; Newell JB; Wedeen VJ; Rosen BR; Brady TJ; Okada RD J Nucl Med; 1987 May; 28(5):871-7. PubMed ID: 3572546 [TBL] [Abstract][Full Text] [Related]
6. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging. Schmiedl U; Brasch RC; Ogan MD; Moseley ME Acta Radiol Suppl; 1990; 374():99-102. PubMed ID: 1966977 [TBL] [Abstract][Full Text] [Related]
7. [Usefulness of MRI with Gd-DTPA in brain tumors]. Sakamoto Y; Takahashi M; Miyawaki M; Bussaka H; Wakamatsu H Rinsho Hoshasen; 1988 Apr; 33(4):435-8. PubMed ID: 3398269 [No Abstract] [Full Text] [Related]
8. [Gd-DTPA in the diagnosis of brain metastasis]. Kornienko VN; Pronin IN Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209 [TBL] [Abstract][Full Text] [Related]
9. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images]. Mano I; Yoshida H; Kono T; Tsuchida T; Terao H; Iio M Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287 [No Abstract] [Full Text] [Related]
10. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related]
11. [MRI of retroperitoneal lesions using a rapid pulse sequence method and Gd-DTPA enhancement]. Yoshida H; Yashiro N; Iio M; Mano I Rinsho Hoshasen; 1988 Apr; 33(4):461-6. PubMed ID: 3398273 [No Abstract] [Full Text] [Related]
12. Double contrast MR imaging with iron colloid and Gd-DTPA in cholangiocellular carcinoma. Suto Y; Shimatani Y; Kato T; Kamba M; Ohuchi Y; Kodama F; Kato T; Ohta Y Acta Radiol; 1994 Nov; 35(6):632-3. PubMed ID: 7946691 [TBL] [Abstract][Full Text] [Related]
14. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging. Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557 [TBL] [Abstract][Full Text] [Related]
15. Functional imaging of the heart. Role of magnetic resonance imaging contrast media. Higgins CB Invest Radiol; 1993 Sep; 28 Suppl 4():S38-42. PubMed ID: 8225901 [No Abstract] [Full Text] [Related]
16. [Spontaneous aseptic osteonecrosis of the knee (Ahlbäck's disease). NMR imaging using GD-DTPA]. Zelder J; Benning R; Walthers E Rofo; 1994 Aug; 161(2):139-41. PubMed ID: 8054546 [TBL] [Abstract][Full Text] [Related]
17. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity]. Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501 [TBL] [Abstract][Full Text] [Related]
18. [Preparation of a novel targeted MR contrast agent Gd-DTPA-streptavidin and exploration of its reaction conditions]. Liu X; Xu YK; Huang QL Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):15-7. PubMed ID: 14724085 [TBL] [Abstract][Full Text] [Related]
19. [The value of gadolinium-DTPA in the study of the urinary bladder]. Beyer HK; Blümm R; Hötzinger H Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435 [No Abstract] [Full Text] [Related]
20. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media]. De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]